RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain
- 10 October 2011
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 155 (1), 18-25
- https://doi.org/10.1016/j.jconrel.2010.08.011
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene deliveryChemical Communications, 2009
- Nonviral Approaches for Neuronal Delivery of Nucleic AcidsPharmaceutical Research, 2007
- Blood–brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horsesJournal of Controlled Release, 2007
- Breaking up the correlation between efficacy and toxicity for nonviral gene deliveryProceedings of the National Academy of Sciences of the United States of America, 2007
- Transvascular delivery of small interfering RNA to the central nervous systemNature, 2007
- Nanoprobes with near-infrared persistent luminescence for in vivo imagingProceedings of the National Academy of Sciences of the United States of America, 2007
- Efficient gene delivery targeted to the brain using a transferrin‐conjugated polyethyleneglycol‐modified polyamidoamine dendrimerThe FASEB Journal, 2007
- Gene‐based treatment of motor neuron diseasesMuscle & Nerve, 2005
- Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain CancerClinical Cancer Research, 2004
- Gene Therapeutic Strategies for Neuroprotection: Implications for Parkinson's DiseaseExperimental Neurology, 1997